Iovance Biotherapeutics, Inc. · 2 hours ago
Cell Therapy Account Management - North Carolina/South Carolina
North Carolina
Full-time
Hybrid
Mid, Senior Level
2+ years expIovance Biotherapeutics is a leader in cell therapy treatments for advanced melanoma. They are seeking a Cell Therapy Account Management Associate to drive demand for their product Amtagvi, develop referral networks, and collaborate with internal teams to ensure operational excellence in account management.
BiotechnologyClinical TrialsHealth CareHealth DiagnosticsMedical
Responsibilities
Drive AmtagviTM demand and appropriate pull-through at targeted ATCs and serve as a liaison between community oncology practices and internal stakeholders to align initiatives with business and medical objectives
Collaborates closely with Iovance iPOD at authorized treatment centers offering commercially available AmtagviTM. Responsible for developing and onboarding a new TIL service line at target ATCs
Educate site personnel on clinical and product information for AmtagviTM
Provide knowledge around Iovance products and processes to all service line customer stakeholders
Collaborate with ATC Operations, to ensure Iovance Cell Therapy logistics, processes, and operations
Provide customer service while building business relationships with key clinical thought leaders, AmtagviTM prescribers, and other institutional stakeholders to influence the uptake of AmtagviTM
Develop and maintain applicable disease state, product-specific (AmtagviTM), and understanding of the competitive landscape within assigned territory
Attend and support professional meetings and congresses regionally and nationally
Facilitate engagement with key thought leaders, Cell Therapy prescribers, and other institutional stakeholders
Collaborate with Iovance cross-functional partners in Market Access, Operations, Quality, Marketing, Medical, and others to ensure appropriate patient identification, infusion of AmtagviTM, and clinical care related to AmtagviTM
Provide timely feedback to appropriate Iovance management regarding account business trends, changes in the therapeutic landscape, industry issues, and business opportunities
Collaborate with the sales leadership team to develop and implement strategic account plans in qualified academic institutions and large community medical oncology practices
Maintain compliance with US/global healthcare laws and regulations
Exemplify Iovance Biotherapeutics’ core values, policies, procedures, and business ethics
Perform miscellaneous duties as assigned
Qualification
Required
The ideal candidate will live in North Carolina or South Carolina
2-7 years of related experience with a bachelor's degree; or 3 years and a master's degree; or a PhD without experience; or equivalent work experience in a similar role within oncology/cell therapy or rare disease
Ability and desire to provide customer support across stakeholder groups
Understanding of the oncology and immunotherapy market, including reimbursement and policy landscape within academic hospitals, oncology clinics, and extensive community practices
Understanding of products and therapies requiring complex delivery systems, including logistics management and regulatory and compliance requirements (i.e., GMP, Quality systems)
Ability to successfully work and collaborate with field-based and internal cross-functional partners
Understanding of how to utilize data analytics to inform decision-making and planning around Amtagvi's uptake strategy
Demonstrate initiative, high sense of urgency, and perseverance in a fast-paced, entrepreneurial environment
Must have a valid driver's license
Preferred
Experience developing and building service lines at academic hospitals (preferred)
Oncology/cell therapy or rare disease experience preferred
MBA or other related graduate-level degree is preferred
Experience with new product launches is preferred
Company
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.58B2024-02-20Post Ipo Equity· $211M
2023-07-10Post Ipo Equity· $150M
2020-05-27Post Ipo Equity· $603.7M
Leadership Team
Jean-Marc Bellemin
Chief Financial Officer
Cheryl Aranda
Executive Assistant to Chief Medical Officer
Recent News
2025-12-29
2025-12-07
2025-11-11
Company data provided by crunchbase